PatientBond announces the appointment of Justin Dearborn as CEO and the Closing of its Series C Round of Funding
- S&P 500, Dow climb for third day and close at records
- Tesla (TSLA) China Numbers 'Robust' - Wedbush
- Apple (AAPL) Shares Seen as 'Attractive' as Recent Checks Show Continuously Strong Demand - Citi
- Amazon.com warehouse workers vote to reject forming union in Alabama
Get instant alerts when news breaks on your stocks. Claim your 1-week free trial to StreetInsider Premium here.
SALT LAKE CITY, Feb. 4, 2021 /PRNewswire/ -- PatientBond, a leading patient engagement SAAS provider, today announced that Justin Dearborn has been named as Chief Executive Officer and that the Company has closed its Series C financing. Anurag Juneja, who has been Chief Executive Officer since co-founding the company will continue as President.
Dearborn has over 25 years of experience as an executive for healthcare, technology and software companies including a successful turnaround of Merge Healthcare where he grew the business from a $10 million enterprise value to a sale to IBM for $1 billion.
"Justin is the right leader for PatientBond, and we are very excited to have him on board," said Jonathan Phillips, PatientBond's Chairman of the Board. "Justin's extensive technology background and business development skills will assist PatientBond as we continue our upward momentum. We believe his strong leadership experience will complement the great team at PatientBond as we prepare for the next stage of growth, similar to what he was able to achieve in growing Merge Healthcare's revenue by a factor of ten."
"I am very excited to be joining the PatientBond team," said Dearborn. "PatientBond has a great value proposition, evidenced by their industry-leading 82 NPS, and a talented management team. PatientBond is uniquely positioned to capitalize on the continued focus of healthcare payers, providers and life science companies on digital engagement with members, patients and users.
PatientBond notes the new funding will be used to rapidly expand the company's go-to-market offerings, including its industry leading customer success team, which have driven PatientBond's recognition as a top-tier company in the Inc. 5000 list of fastest growing companies two years running and recognition in the Financial Times "America's Fastest Growing Companies 2020." All existing investors participated in the oversubscribed Series C with the addition of five family offices and one venture group.
About PatientBondPatientBond's mission is to leverage Healthcare Consumer Insights and Innovative Technology Solutions to help its clients better navigate the rise of consumerism in healthcare and evolving reimbursement models. PatientBond's highly configurable communications platform leverages a proven psychographic segmentation model and a diverse set of digital workflows to help our clients build a tighter bond with their patients to improve health outcomes, grow their market share, and improve patient payment collections. PatientBond is currently used by over 1,200 healthcare provider locations across the United States. PatientBond is a portfolio company of First Health Capital Partners, LLC. Information about PatientBond is available at www.patientbond.com
View original content to download multimedia:http://www.prnewswire.com/news-releases/patientbond-announces-the-appointment-of-justin-dearborn-as-ceo-and-the-closing-of-its-series-c-round-of-funding-301221479.html
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Snowboarders set to swap snowy slopes for sand dunes of Qatar
- Sunrun Solar to Help Small Businesses Benefit From Solar Rebate